Revolutionizing Natural Medicine with AI
A NEXT GENERATION
PHARMACOGNOSY* PLATFORM
Revolutionizing Natural Medicine with AI
A NEXT GENERATION
PHARMACOGNOSY* PLATFORM
A NEXT GENERATION
PHARMACOGNOSY* PLATFORM
A NEXT GENERATION
PHARMACOGNOSY* PLATFORM

At PlantRx, we strive to revolutionize the field of pharmacognosy through advanced AI technology. Our goal is to identify and develop small molecule therapeutics that are derived from natural products, ensuring efficacy and safety.


Discovery of the benefits or side effects of molecules has been limited to expensive and time consuming wet-chemistry techniques.
With the growth of supercomputing abilities, it is now possible to do large-scale docking studies to better understand these molecules. AI further enables that understanding.

Jim serves as Chair of Positive Growth Ventures (d/b/a Acannability), bringing a career focus in emerging markets, new technology, and industry standards. Jim is an inductee of the Chicago Area Entrepreneurship Hall of Fame by the Institute for Entrepreneurial Studies at the UIC College of Business Administration.

Mika is an award-winning journalist and dynamic entrepreneur known for her creative strategies in executing media and communication campaigns. Throughout her career, she’s been recognized for her creativity, hustle, and leadership, including winning an Emmy in 2008 as a Field Producer at CBS 2 News Chicago.

Rachel has an MBA from the University of Pennsylvania . She is a seasoned attorney with over two decades of experience, specializing in intellectual property (IP) and its strategic use to drive business goals. She previously served as in-house counsel for a pharmaceutical company, focusing on IP strategy, licensing, and litigation.

Matt is the D. Gale Johnson Service Professor Emeritus of Molecular Engineering at the University of Chicago. He was senior advisor at the Argonne National Laboratory until 2023. Tirrell's research focuses on the interfacial phenomena organic material systems.

Dr. DJ Nag is the President of Innovaito, an IP strategy advisory company partnering with the top academic and research institutions. He currently serves as an independent board member at Crown Electrokinetics Inc. His professional career spans the intersection of intellectual property strategy, technology transfer, and academic leadership.

Dr. Niven R. Narain is President and CEO of BPGbio Inc, a leading AI-powered, biology-focused biopharma company in Boston, MA. He is recognized as a pioneer in the intersection of Biology and AI and led the development the NAi Interrogative Biology® platform which has advanced late-stage pipeline of assets in Oncology, CNS, and rare inflammatory diseases.

Malaika Bhayana is a Duke University, class of 2024, Biophysics graduate with a strong background in science, business strategy, and innovation. She has worked with organizations such as United Therapeutics, the NIH, and the Duke Clinical Research Institute, gaining experience in clinical research and global communications in the life sciences and biotech sectors.
If you have questions about the opportunities available to you in our programs, feel free to send us a message. We will get back to you as soon as possible.


Copyright © 2025 PlantRx - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.